Novavax (NVAX) and Sanofi (SNY) Enter Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. CRL

Go back to Novavax (NVAX) and Sanofi (SNY) Enter Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.63 +0.03 (0.28%)
Previous Close $10.60    52 Week High $9.23 
Open $10.62    52 Week Low $1.16 
Day High $10.79    P/E N/A 
Day Low $10.34    EPS $-0.30 
Volume 3,910,064       

SANOFI (NASDAQ: SNY) Delayed: 41.11 +0.17 (0.42%)
Previous Close $40.94    52 Week High $44.76 
Open $40.89    52 Week Low $36.81 
Day High $41.12    P/E N/A 
Day Low $40.66    EPS $0.00 
Volume 2,216,924